Study Title
A Clinical Imaging Study Using [18F]F-AraG PET to Visualize Tumor Infiltrating T-cell Activation in Non-small Cell Lung Cancer.
Study Details
Description:
[18F]F-AraG is a promising tracer to image activated T-cells with positron emission tomography (PET). The aim of the ATTAIN trial is to investigate the pharmacokinetic characteristics of this novel tracer by performing a full kinetic modelling, assess test-retest (TRT) variability and to correlate the tumor tracer uptake with the pathological assessment.
Sponsor:
Amsterdam University Medical CenterContacts:
Contact: I. Bahce, MD, PhDlong@vumc.nl
+31204444782
Government Study Link:
NCT05157659 - Click here to see study onClinicalTrials.gov